TRUE Stock Overview
Treatment.Com International Inc. provides personalized health care information services in Canada. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Treatment.com AI Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.53 |
52 Week High | CA$1.11 |
52 Week Low | CA$0.35 |
Beta | -0.58 |
1 Month Change | -1.85% |
3 Month Change | -27.40% |
1 Year Change | 20.45% |
3 Year Change | -94.18% |
5 Year Change | n/a |
Change since IPO | -98.32% |
Recent News & Updates
Shareholder Returns
TRUE | CA Healthcare Services | CA Market | |
---|---|---|---|
7D | -5.4% | -3.1% | -2.6% |
1Y | 20.5% | 120.7% | 15.2% |
Return vs Industry: TRUE underperformed the Canadian Healthcare Services industry which returned 117.1% over the past year.
Return vs Market: TRUE exceeded the Canadian Market which returned 15% over the past year.
Price Volatility
TRUE volatility | |
---|---|
TRUE Average Weekly Movement | 10.9% |
Healthcare Services Industry Average Movement | 9.4% |
Market Average Movement | 8.1% |
10% most volatile stocks in CA Market | 17.3% |
10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: TRUE has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: TRUE's weekly volatility (11%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2018 | n/a | Essam Hamza | www.treatment.com |
Treatment Com International Inc. provides personalized health care information services in Canada. The company develops a mobile application for symptom assessment of users to address their health concerns, problems, and ongoing wellness management.
Treatment.com AI Inc. Fundamentals Summary
TRUE fundamental statistics | |
---|---|
Market cap | CA$25.96m |
Earnings (TTM) | -CA$2.01m |
Revenue (TTM) | CA$38.14k |
680.8x
P/S Ratio-12.9x
P/E RatioIs TRUE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
TRUE income statement (TTM) | |
---|---|
Revenue | CA$38.14k |
Cost of Revenue | CA$13.95k |
Gross Profit | CA$24.19k |
Other Expenses | CA$2.03m |
Earnings | -CA$2.01m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.041 |
Gross Margin | 63.43% |
Net Profit Margin | -5,268.63% |
Debt/Equity Ratio | -91.6% |
How did TRUE perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/20 16:54 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2023/09/30 |
Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Treatment.com AI Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|